CareRx (CRRX) was up 8% on no news but it’s ripped 80% this year, so I wanted to put it on your radar. Through M&A the company became the largest pharmacy services provider to the senior living industry…

… but more recently, it’s taken its foot off the gas on dealmaking to focus on improving the margin profile…

… and reducing the debt load, two items that weighed on shares in years past. With the balance sheet now in great shape, management is open to deploying capital…

… but is likely to take a more measured approach this time around, with an ~8% organic growth outlook…

❝

I think I’ve publicly stated 6,000 to 8,000 (beds) was our target for this year. We are comfortable for that same target next year for what we see in the pipeline.

Puneet Khanna (CEO) - CRRX Q3’25 call

… supported by growing bed supply and industry consolidation - with acquisitions by Extendicare, Chartwell, and Sienna (all clients) opening the door for new business. With valuation in-line with its long-term average…

… might not be a bad time to sharpen your pencils.

You might be interested in…

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.